TY - JOUR
T1 - Exploring primary care physician feedback following an integrative oncology consultation
AU - Hauzer, Michael
AU - Grimberg, Ran
AU - Samuels, Noah
AU - Keshet, Yael
AU - Mordechai, Alperin
AU - Dagash, Jamal
AU - Ben-Arye, Eran
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2023/10
Y1 - 2023/10
N2 - Objective: To explore responses from primary care physicians (PCPs) from an integrative physician (IP) consultation and recommended integrative oncology (IO) treatment program. Methods: Chemotherapy-treated patients were referred by their oncology healthcare professional to an IP, a physician dually trained in complementary medicine and supportive cancer care. The consultation summary and patient-centered IO treatment program was then sent to the patient’s PCP, with PCP-to-IP responses analyzed qualitatively using ATLAS.Ti software for systematic coding and content analysis. Trial Registration Number NCT01860365 published May 22, 2013. Results: Of the 597 IP consultations conducted, 470 (78.7%) summaries were sent to patients’ PCPs, with only 69 (14.7%) PCP-to-IP responses returned. PCPs were more likely to respond if the patient was Hebrew-speaking (78.3% vs. 65.1%, P = 0.032). Systematic coding identified four predominant themes among PCP narratives: addressing the patient’s medical condition and leading QoL-related concerns; patient-centered reflections; available resources providing support and promoting resilience; and PCP attitudes to the IO treatment program. Conclusion: PCP-IP communication can provide valuable insight into the patient’s bio-psycho-social care, addressing the patient’s health-belief model, emotional concerns, caregiver-related factors, preferences, and barriers to adherence to IO care. Practice implications: Healthcare services should consider promoting IP-PCP communication in order to facilitate better patient outcomes from an IO treatment program.
AB - Objective: To explore responses from primary care physicians (PCPs) from an integrative physician (IP) consultation and recommended integrative oncology (IO) treatment program. Methods: Chemotherapy-treated patients were referred by their oncology healthcare professional to an IP, a physician dually trained in complementary medicine and supportive cancer care. The consultation summary and patient-centered IO treatment program was then sent to the patient’s PCP, with PCP-to-IP responses analyzed qualitatively using ATLAS.Ti software for systematic coding and content analysis. Trial Registration Number NCT01860365 published May 22, 2013. Results: Of the 597 IP consultations conducted, 470 (78.7%) summaries were sent to patients’ PCPs, with only 69 (14.7%) PCP-to-IP responses returned. PCPs were more likely to respond if the patient was Hebrew-speaking (78.3% vs. 65.1%, P = 0.032). Systematic coding identified four predominant themes among PCP narratives: addressing the patient’s medical condition and leading QoL-related concerns; patient-centered reflections; available resources providing support and promoting resilience; and PCP attitudes to the IO treatment program. Conclusion: PCP-IP communication can provide valuable insight into the patient’s bio-psycho-social care, addressing the patient’s health-belief model, emotional concerns, caregiver-related factors, preferences, and barriers to adherence to IO care. Practice implications: Healthcare services should consider promoting IP-PCP communication in order to facilitate better patient outcomes from an IO treatment program.
KW - Doctor-patient communication
KW - Integrative medicine
KW - Integrative oncology
KW - Patient-centered care
KW - Primary care physician
UR - http://www.scopus.com/inward/record.url?scp=85173024407&partnerID=8YFLogxK
U2 - 10.1007/s00520-023-08079-6
DO - 10.1007/s00520-023-08079-6
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37787815
AN - SCOPUS:85173024407
SN - 0941-4355
VL - 31
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 10
M1 - 606
ER -